Advertisement

Topics

Latest Cardiovascular disease (CVD) NewsRSS

07:58 EST 22nd November 2017 | BioPortfolio

Ventricular Tachycardia Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

Ventricular Tachycardia Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia Pipeline Review, H2 2017, provides an overview of the Ventricular Tachycardia Cardiovascular pipeline landscape.Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia incl...

Myocarditis more prevalent in young boys than girls

Cardiac disease myocarditis has historically affected more men than

Long-term Canakinumab Treatment Lowering Inflammation Independent of Lipid Levels for Residual Inflammatory Risk Benefit – Personalized Medicine for Recurrent MI, Strokes and Cardiovascular Death

Long-term Canakinumab Treatment Lowering Inflammation Independent of Lipid Levels for Residual Inflammatory Risk Benefit – Personalized Medicine for Recurrent MI, Strokes and Cardiovascular Death   Reporter: Aviva Lev-Ari, PhD, RN   Major findings from the trial were presented earlier this year. The trial was designed to test whether canakinumab, which lowers inflammation independe...

Startup seeking to resurrect Vioxx, arthritis drug pulled from market

Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke.

Startup Could Bring Back Vioxx For Hemophilia

NewsAPNewsBreak: Merck & Co. voluntarily pulled Vioxx in 2004 amid evidence that it doubled the chances of having a heart attack or stroke. Now tiny Tremeau Pharmaceuticals is working to bring it back.

CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the publication of two new papers. These joint public...

APNewsbreak: Startup could bring back Vioxx for hemophilia

Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke.

Male Triathletes May Be Putting Their Heart Health at Risk

Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis

Dog Ownership Linked to Lower Mortality

Study shows that dog owners had a lower risk of death due to cardiovascular disease or to other causes

Global and Regional Central Venous Catheters Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

SummaryA central venous catheter, also called a central line, is a long, thin, flexible tube used to give medicines, fluids, nutrients, or blood products over a long period of time, usually several weeks or more. A catheter is often inserted in the arm or chest through the skin into a large vein. The catheter is threaded through this vein until it reaches a large vein near the heart.Market Segment...

Study: More ‘good’ cholesterol doesn’t reduce CVD risk if ‘bad’ cholesterol stays same

New research suggests greater amounts of high-density lipoprotein (HDL)

Aramark Serves up 14 Percent Reduction in Sodium Through Healthy Menu Innovation as New American Heart Association Hypertension Guidelines Emphasize Lifestyle Modifications

Healthy for Life initiative on track to achieve 2020 goals impacting the health & well-being of millions of Americans Aramark, the largest U.S. food service company serving two billion meals each year and the American Heart Association, the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseas...

Proper BP measurement crucial as clinicians adapt to new guidelines

Body:  Blood pressure has been in mainstream, national news media over the last week in response to the American Heart Association and the American College of Cardiology updating the U.S. hypertension guidelines for the first time in 14 years.But while much of the discussion has centered on the lower threshold for hypertension (130/80 millimeters of mercury) and what it means for clinical pra...

WHOOP Takes on the Stress of the Season with the “Thrive the Holidays” Challenge

Get WHOOP, Share WHOOP. From Black Friday to Cyber Monday, buy one WHOOP strap and give one to another for free. WHOOP, the human performance company, today announced the “Thrive the Holidays” challenge, a call to rise up and beat the stress of the season with WHOOP. Starting on Black Friday through midnight on Cyber Monday (...

Acute Heart failure AHF Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Acute Heart failure AHF Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Acute Heart failure AHF Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 2...

This Man's Mother Inspired Him to Make a Positive Difference Every Day

HP's Michael Padilla fights for his best friend and other cancer patients. SOURCE: HP, Inc. DESCRIPTION:Life is an incredible journey. Every day is a beautiful gift and an opportunity to make a positive difference. I learned this at an early age watching how hard my mom, Sharon, worked to make sure we had the best life possible. At times, she worked multiple jobs so that we had all that we ne...

What is “integrative oncology”? Even the Society for Integrative Oncology doesn’t seem to know for sure

Last week, the Society for Integrative Oncology published an article attempting to define what "integrative oncology" is. The definition, when it isn't totally vague, ignores the pseudoscience at the heart of integrative oncology and medicine.

Navamedic ASA: Enters into long-term agreement for distribution of GoNitro®* in the Nordics

   Oslo, November 20, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a preliminary long-term agreement with G. Pohl-Boskamp GmbH & Co. KG for the Nordic launch and commercialisation of GoNitro®*, a new nitroglycerin sublingual powder formulation for acute relief of an attack or prophylaxis of angi...

BergaMet NA Supplements Coming Soon to VitaBeauti.com

BergaMet NA’s bergamot-based cardiovascular health supplements will soon be available on health, wellness and beauty product e-commerce site VitaBeauti.com. BOCA RATON, Fla. (PRWEB) November 20, 2017 BergaMet NA’s bergamot-based cardiovascular health supplements will soon be available on health, wellness and beauty product e-commerce site VitaBeauti.com. A bergamot is a citrus fruit thought ...

Global and Regional Central Venous Catheters Market Research Report 2017 [Report Updated: 06112017] Prices from USD $3500

SummaryA central venous catheter, also called a central line, is a long, thin, flexible tube used to give medicines, fluids, nutrients, or blood products over a long period of time, usually several weeks or more. A catheter is often inserted in the arm or chest through the skin into a large vein. The catheter is threaded through this vein until it reaches a large vein near the heart.Market Segment...

Global Coronary Artery Disease Therapeutics Market Size and Forecast by Technavio

According to the latest market study released by Technavio, the global coronary artery disease therapeutics market is expected to grow at a CAGR of more than 5% during the forecast period. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005036/en/

AMPK activator reduces glucose level in type 2 diabetes in phase 2a trial

A novel AMP-activated protein kinase activator showed glucose reduction and decreased cardiovascular risk factors in people with type 2 diabetes in a phase 2a trial, according to a press release from the drug’s developer.The first-in-class drug (O304, Betagenon/Baltic Bio) activates AMP-activated protein kinase (AMPK), which regulates energy balance. By activating this protein, the researchers a...

Global and Regional Phenylketonuria PKU Market Research Report 2017 [Report Updated: 01011970] Prices from USD $3500

SummaryPhenylketonuria PKU is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.Ma...

Quantum Genomics SA ALQGC Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryQuantum Genomics SA QGS is a biopharmaceutical company that develops therapies in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. carries out research based on the brain aminopeptidase A inhibition, which is a triple action therapeutic platform. QGS's research programs include QGC001 for the treatment of high blood pressure wi...

Global Heart Lung Machine Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryHeart Lung Machine is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heartlung machine is often referred to as the pump, and does the work of the heart and lungs during the operation.The global Heart Lung Machine market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report includin...

Quick Search
Advertisement
 

review and buy Cardiovascular disease (CVD) market research data and corporate reports here